These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30892934)

  • 21. Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus.
    Lavi Arab F; Rastin M; Faraji F; Zamani Taghizadeh Rabe S; Tabasi N; Khazaee M; Haghmorad D; Mahmoudi M
    Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):12-8. PubMed ID: 25318538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD(+)(4)CD(+)(25) Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients.
    Huang H; Sun W; Liang Y; Long XD; Peng Y; Liu Z; Wen X; Jia M
    Ren Fail; 2014 Sep; 36(8):1263-7. PubMed ID: 24990576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
    An N; Chen Y; Wang C; Yang C; Wu ZH; Xue J; Ye L; Wang S; Liu HF; Pan Q
    Cell Physiol Biochem; 2017; 44(1):412-422. PubMed ID: 29141242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose IL-2 therapy limits the reduction in absolute numbers of peripheral lymphocytes in systemic lupus erythematosus patients with infection.
    Zhang JQ; Zhang SX; Wang J; Qiao J; Qiu MT; Wu XY; Chen JW; Gao C; Li XF
    Curr Med Res Opin; 2022 Jun; 38(6):1037-1044. PubMed ID: 35414310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of human amniotic epithelial cells in murine models of Hashimoto's thyroiditis and Systemic lupus erythematosus.
    Tan B; Yuan W; Li J; Yang P; Ge Z; Liu J; Qiu C; Zhu X; Qiu C; Lai D; Guo L; Wang L; Yu L
    Cytotherapy; 2018 Oct; 20(10):1247-1258. PubMed ID: 30174233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leptin antagonism attenuates hypertension and renal injury in an experimental model of autoimmune disease.
    Kalusche WJ; Case CT; Taylor EB
    Clin Sci (Lond); 2023 Dec; 137(23):1771-1785. PubMed ID: 38031726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.
    Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C
    Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
    Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
    Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients.
    Chen M; Chen X; Wan Q
    Eur J Clin Invest; 2018 Nov; 48(11):e13012. PubMed ID: 30079446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory T cells in systemic lupus erythematosus.
    Ohl K; Tenbrock K
    Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.
    Yang J; Chu Y; Yang X; Gao D; Zhu L; Yang X; Wan L; Li M
    Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus.
    Gilbert EL; Mathis KW; Ryan MJ
    Hypertension; 2014 Mar; 63(3):616-23. PubMed ID: 24366082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH; Anderson M; Le E; La Cava A
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.
    He J; Zhang X; Wei Y; Sun X; Chen Y; Deng J; Jin Y; Gan Y; Hu X; Jia R; Xu C; Hou Z; Leong YA; Zhu L; Feng J; An Y; Jia Y; Li C; Liu X; Ye H; Ren L; Li R; Yao H; Li Y; Chen S; Zhang X; Su Y; Guo J; Shen N; Morand EF; Yu D; Li Z
    Nat Med; 2016 Sep; 22(9):991-3. PubMed ID: 27500725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves.
    Mathis KW; Venegas-Pont M; Flynn ER; Williams JM; Maric-Bilkan C; Dwyer TM; Ryan MJ
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R711-9. PubMed ID: 23926131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus.
    Nakagawa P; Masjoan-Juncos JX; Basha H; Janic B; Worou ME; Liao TD; Romero CA; Peterson EL; Carretero OA
    Physiol Rep; 2017 Jan; 5(2):. PubMed ID: 28126732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus.
    Comte D; Karampetsou MP; Kis-Toth K; Yoshida N; Bradley SJ; Mizui M; Kono M; Solomon JR; Kyttaris VC; Tsokos GC
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9321-6. PubMed ID: 27482100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus.
    Tsai YG; Liao PF; Hsiao KH; Wu HM; Lin CY; Yang KD
    Front Immunol; 2023; 14():1230264. PubMed ID: 37771588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Regulatory T-cells in systemic lupus erythematosus. IL-2 is decisive for loss of tolerance].
    Ohl K; Tenbrock K
    Z Rheumatol; 2016 Apr; 75(3):253-64. PubMed ID: 26975190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.